Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Chronic migraine: Multiple cranial nerve blocks may be an effective prevention therapy

Publish date:: May 22, 2020

Key clinical point: Repetitive multiple cranial nerve blocks (MCNBs) may be an effective prevention therapy in patients with chronic migraine.

Major finding: At 4 weeks, MCNBs significantly reduced headache days (mean, 5.4 days; P less than .001). The response rate was significantly (P = .009) higher in patients with migraine with aura compared with those without.

Study details: A single-center, prospective, nonrandomized cohort study of 64 patients with chronic migraine who underwent ≥1 MCNB procedure.

Disclosures: No funding was received and the authors declared no conflict of interest.

Citation:

Fernandes L et al. Headache. 2020 Mar 30. doi: 10.1111/head.13792.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,